Pathology News
NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a frontier clinical artificial intelligence (AI) company developing AI-powered tools for oncology, today announced that its laboratory has received accreditation from the College of American...
From the Gestalt blog: Healthcare IT isn’t shrinking, it’s resetting. After the surge of pandemic-era hiring, many health systems are stepping back and asking a hard question: does more headcount actually make us more agile? In 2026,...
From Proscia on LinkedIn When evaluating an enterprise pathology platform, many life sciences organizations and diagnostic laboratories focus on the features it offers. This makes sense since scientists and pathologists will rely on that...
Nucleai, Gilead, and target-positive tumors Antibody-drug conjugates (ADCs) have emerged as one of the busiest and most crowded niches within oncology, given their potential to use an antibody to ferry a potent cytotoxic payload toward...
aetherAI: Delivering Integrated Software-and-Hardware Consulting Solutions for the Global Digital Transformation of Pathology — Growth Momentum Poised to Accelerate aetherAI (7803), a global leader in digital pathology and AI healthcare...
The partnership brings elea’s pathology-specific AI directly into Techcyte Fusion, enabling pathologists to turn assessments into structured, coded reports. OREM, UT, UNITED STATES, August 13, 2026 /EINPresswire.com/ -- Techcyte today...
